Refractory acute myeloid leukemia
Clinical trials for Refractory acute myeloid leukemia explained in plain language.
Never miss a new study
Get alerted when new Refractory acute myeloid leukemia trials appear
Sign up with your email to follow new studies for Refractory acute myeloid leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new combo drug tame childhood leukemia that Won't quit?
Disease control Not yet recruitingThis trial is investigating whether a new drug called sonrotoclax, when combined with other anti-cancer medicines, is safe and effective for children and adolescents with acute myeloid leukemia (AML) or B-cell acute lymphoblastic leukemia (ALL) that has returned or not responded …
Matched conditions: REFRACTORY ACUTE MYELOID LEUKEMIA
Phase 1/2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Not yet recruitingThis early-phase trial is testing a new personalized therapy called BSB-2002 for adults with a specific type of acute myeloid leukemia (AML) that has come back or not responded to treatment. The therapy uses a patient's own immune cells (T cells) that are genetically modified to …
Matched conditions: REFRACTORY ACUTE MYELOID LEUKEMIA
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC